Myvideo

Guest

Login

ESMO 2018 Congress: Highlights in HR-positive, HER2-negative advanced breast cancer LBA2_PR

Uploaded By: Myvideo
19 views
0
0 votes
0
AboutShareDownloadAdd to

Dr. Massimo Cristofanilli reports on key results from ESMO 2018 Congress: LBA2_PR: Overall survival with palbociclib plus fulvestrant in women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: Analyses from PALOMA-3. Produced by the European Society for Medical Oncology

Share with your friends

Link:

Embed:

Video Size:

Custom size:

x
Share this video

Copy Link:

Google Plus

Add to Playlist:

Favorites
My Playlist
Watch Later
Add to
Favorites
My Playlist
Watch Later
Similar VideosComments
2019-09-08 нед. 12-я Проповедь о. Александра Сорокина на (Мф 19, 16-26):Watch Video
1 year ago
00:08:49
2019-09-08 нед. 12-я Проповедь о. Александра Сорокина на (Мф 19, 16-26):
1 37%
Visions of Atlantis 07Feb2023 4K60 HQ audio - epic, dramatic and all that! @1720, Los Angeles 90021Watch Video
2 years ago
00:39:15
Visions of Atlantis 07Feb2023 4K60 HQ audio - epic, dramatic and all that! @1720, Los Angeles 90021
3 77%
ESMO 2018 Congress: Highlights in HR-positive, HER2-negative advanced breast cancer LBA2_PRWatch Video
6 years ago
00:01:26
ESMO 2018 Congress: Highlights in HR-positive, HER2-negative advanced breast cancer LBA2_PR
19 59%
0 Comments
Guest